U.S. Stock News

Over the last 7 days, the United States market has experienced a slight decline of 1.5%, yet it has shown robust growth over the past year with an increase of 18%, and earnings are expected to continue growing at a rate of 17% annually. In this context, identifying stocks that are estimated to be below their fair value can be particularly appealing for investors seeking potential opportunities amidst fluctuating market conditions.

Over the last 7 days, the United States market has dropped 1.5%, yet it has shown resilience with an 18% increase over the past year and an annual earnings growth forecast of 17%. In such a fluctuating environment, growth stocks with high insider ownership can be appealing as they often indicate strong confidence from those closest to the company in its long-term potential.

Over the last 7 days, the U.S. market has dropped 1.5%, but it has risen by 18% over the past year, with earnings forecasted to grow by 17% annually. For investors willing to explore beyond established names, penny stocks—often smaller or newer companies—can present intriguing opportunities despite their somewhat outdated label. By focusing on those with strong financials and a clear growth path, investors can discover promising options that balance potential upside with stability.

Moody’s recent affirmation of Las Vegas Sands (LVS) credit ratings with a stable outlook has put the stock back in focus for investors watching casino operators with large Asian resort exposure. See our latest analysis for Las Vegas Sands. Despite Moody’s affirmation, Las Vegas Sands’ share price has been under pressure, with the stock down 28% year to date and the 1 year total shareholder return declining 15%, signalling fading momentum even as credit confidence remains intact. If you are...

Arcus Biosciences (RCUS) continues to attract attention after recent share price moves, with the stock closing at US$30.12. Investors are weighing its clinical-stage cancer pipeline and its latest trading performance. See our latest analysis for Arcus Biosciences. The recent move to US$30.12 comes after a mixed near term patch, with the 1-day share price return slightly down, but a 90-day share price return of 24.82% and a 1-year total shareholder return of 196.75% point to strong underlying...

In August 2026, Eton Pharmaceuticals reported second-quarter 2026 results showing revenue of US$37.59 million and net income of US$11.58 million, reversing a loss in the prior-year period and turning earnings per share from a loss to US$0.35 on a diluted basis. Alongside this earnings improvement, the company raised its 2026 annual revenue guidance to at least US$145 million, suggesting management sees the recent performance as part of a broader shift in its operating profile. With this...

Corpay’s European T20 Premier League Agreement Corpay (CPAY) has secured a new client agreement with the European T20 Premier League, becoming the tournament’s exclusive foreign exchange partner and provider of FX risk management and global payments solutions. See our latest analysis for Corpay. The new European T20 Premier League agreement comes as Corpay’s share price sits at US$413.92, with a 30-day share price return of 11.70% and a 90-day share price return of 18.39%. Over longer...

As the U.S.-Canada trade war heats up, with fresh 50% tariffs and warnings about energy and critical minerals, utilities and power generators are suddenly on the front line of a political story that hits real assets and real bills. For investors, stress in cross-border supply chains can reshape where money flows. This article walks through 3 stocks exposed to this news so you can judge the risks and potential resilience. The three stocks covered next are only a starting point, and the full...

Proto Labs has appointed manufacturing veteran Sam Ramahi as Chief Operations Officer, effective August 31, 2026, to oversee global operations, supply chain, quality, sourcing, and continuous improvement under CEO Suresh Krishna’s oversight. Investors are watching how Ramahi’s 25-plus years of transforming complex manufacturing and supply chain organizations might influence Proto Labs’ push to support customers from prototype through production. Next, we’ll examine how Ramahi’s oversight of...

How Marzetti’s latest earnings, buyback and dividend fit together for shareholders Marzetti (MZTI) just reported fourth quarter and full year results alongside a fresh update on its long running buyback and a new quarterly dividend declaration. That combination gives you several angles to assess the stock. For the quarter ended June 30, 2026, Marzetti reported sales of US$465.03 million compared with US$475.43 million a year earlier. Net income was US$48.29 million compared with US$32.53...

Concentra Group Holdings Parent, Inc. announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, rejoined the company on September 1, 2026, and became chief medical officer on January 1, 2027, succeeding longtime CMO Dr. John Anderson after his 33-year tenure. Her combination of clinical leadership at Zenith Insurance Company and presidency of the American College of Occupational and Environmental Medicine brings a rare blend of payer and provider insight to...

In August 2026, Corporación América Airports S.A. reported that second-quarter 2026 sales rose to US$534.04 million and net income to US$52.75 million, with earnings per share from continuing operations improving to US$0.32. Over the first half of 2026, the company increased sales to US$1.07 billion and net income to US$129.61 million, even as quarterly passenger and cargo volumes edged lower. We’ll now examine how this earnings growth, achieved despite slightly softer passenger traffic,...

Old Second Bancorp (OSBC) has filed an omnibus shelf registration of up to $200 million covering common and preferred stock, debt securities, warrants, and other instruments, giving the bank added flexibility for potential future financing. See our latest analysis for Old Second Bancorp. At a share price of $25.45, Old Second Bancorp has a 30.65% year to date share price return and a 41.98% total shareholder return over one year. This points to building momentum around the stock as the new...

Earlier in August 2026, the Illinois Commerce Commission approved ComEd’s Kishwaukee Area Reliability Extension project, authorizing a new double-circuit 345 kV transmission line and substations in DeKalb County to strengthen reliability, support rising demand, and enable more renewable energy connections. At the same time, Exelon backed Federal Energy Regulatory Commission efforts to streamline utility financial reporting, arguing that trimming duplicative Form 3-Q requirements would...

Plains All American Pipeline stock overview Plains All American Pipeline (PAA) has drawn fresh attention after its recent share price move, with the stock closing at $24.96 on 25 August 2026. Investors are assessing how its current valuation lines up with recent returns and fundamentals. See our latest analysis for Plains All American Pipeline. The recent 1-day share price return of 1.42% and 7-day share price return of 5.09% add to a strong year-to-date share price return of 37.07%. Plains...

Why Celanese Stock Is Back In Focus After A New Robotics Partnership Celanese (CE) has drawn fresh attention after signing a partnership with VIGOR Precision to supply specialized plastics and technical support for lightweight humanoid robot joints. See our latest analysis for Celanese. For context, Celanese shares trade at US$45.26 and the stock has climbed 7.35% on a year to date share price return, while the 1 year total shareholder return is down 4.12% and the 5 year total shareholder...

Ituran Location and Control Ltd. reported past second-quarter 2026 results showing higher revenue of US$104.79 million and net income of US$17.33 million year over year, and its Board approved a US$0.50 per-share cash dividend totaling about US$10 million, paid on October 14, 2026 to holders of record on September 29, 2026. Alongside these earnings, the completion of a multi-year buyback of 1,061,286 shares for US$28.92 million underscores management’s ongoing use of cash to return capital...

In recent months, the global watering equipment market has expanded as agriculture and other users prioritize efficient water management and sustainable irrigation solutions, prompting key players like The Toro Company to increase investment in innovation, smart technology, and geographic reach. This broad industry shift toward smarter, conservation-focused watering systems highlights Toro’s potential to benefit from rising demand for advanced irrigation and control technologies across its...

Savara Inc. announced that its Phase 3 IMPALA-2 data for molgramostim in autoimmune pulmonary alveolar proteinosis (aPAP) will be featured in one oral and two poster presentations at the ERS Congress in Barcelona in early September 2026, highlighting long-term efficacy, safety, and biomarker findings. The company emphasized that these results point to sustained improvements in lung function, exercise capacity, and quality of life in aPAP patients, a rare group that currently lacks any...

Envista Holdings Corporation recently appointed President and CEO Paul Keel as Chair of the Board, with former Chair Scott Huennekens transitioning to Lead Independent Director, a move aimed at tightening alignment between the company’s strategy, operations, and long-term value creation. Alongside this leadership consolidation, a recent analyst upgrade and heightened options activity around Envista underline growing attention to the company’s evolving earnings outlook and risk profile. With...

Recent Share Performance And Business Snapshot Molson Coors Beverage (TAP) has drawn renewed investor attention after a period of mixed share performance, with the stock down about 9% year to date but up over the past month and past 3 months. The company has a market value of roughly US$8b and last closed at US$42.99 as of 24 August 2026. Recent annual revenue is US$11.08b with reported net income of US$2.31b loss, and modest annual revenue growth alongside much faster reported net income...

Diodes Incorporated recently completed a US$325,000,000 zero-coupon, senior unsecured convertible notes offering due August 15, 2031, and amended its existing credit agreement to extend its revolving credit facility to August 12, 2031 while updating covenants and pricing. This combination of fresh convertible funding and a longer-dated, more flexible credit facility reshapes the company’s capital structure and liquidity profile in a meaningful way. We’ll now examine how the new zero-coupon...

Global inflation pressures and higher energy costs are pushing central banks toward tighter policy, which keeps borrowing costs elevated and rewards productivity gains. Investors are increasingly looking for businesses that can do more with less. Artificial intelligence sits squarely in that story. This article walks through 3 stocks from an AI Stocks screener that focuses on chips, software and cloud tools tied directly to the ChatGPT and AI wave. The stocks covered below are just a small...

Dave (DAVE) shares have been in focus after the company reported strong second quarter 2026 results and raised its guidance. Investors are now weighing how this update fits with recent board changes. See our latest analysis for Dave. The latest guidance upgrade and board change come as Dave’s share price has a 42.3% 90 day share price return and a 61.7% year to date share price return, while the 3 year total shareholder return is very large. This points to momentum that investors are...